IAG Capital Partners — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Leukoleuko.ioinSep 2022 · $5M
Leuko develops PointCheck, a noninvasive finger-based device that measures white blood cell levels using light imaging and AI to assess infection risk in cancer patients.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Carlos Castro-Gonzalez(Founder)in
Co-investorsNina CapitalGood Growth Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.